SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    EASL Clinical Practice Guidelines: Liver transplantation, Journal of Hepatology, 2016, 64, 2, 433

    CrossRef

  2. 2
    R. San-Juan, O. Manuel, H.H. Hirsch, M. Fernández-Ruiz, F. López-Medrano, P. Comoli, S. Caillard, P. Grossi, J.M. Aguado, Current preventive strategies and management of Epstein–Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey, Clinical Microbiology and Infection, 2015, 21, 6, 604.e1

    CrossRef

  3. 3
    Nishanthi Talawila, Liset H. M. Pengel, Does belatacept improve outcomes for kidney transplant recipients? A systematic review, Transplant International, 2015, 28, 11
  4. 4
    Ana Carolina Amorim Pellicioli, Aline Alves Luciano, Ana Lúcia Carrinho Ayroza Rangel, Greison Rabelo de Oliveira, Alan Roger Santos Silva, Oslei Paes de Almeida, Pablo Agustin Vargas, Epstein-Barr virus (EBV)–associated posttransplant lymphoproliferative disorder appearing as mandibular gingival ulcers, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2015,

    CrossRef

  5. 5
    Ivo Graziadei, Intensivmedizinisches Management vor und nach Lebertransplantation, Wiener klinisches Magazin, 2015, 18, 1, 10

    CrossRef

  6. 6
    Florence Baychelier, Abla Achour, Stéphanie Nguyen, Martine Raphael, Antoine Toubert, Caroline Besson, Armelle Arnoux, Damien Roos-Weil, Michel Marty, Alain Chapelier, Didier Samuel, Patrice Debré, Vincent Vieillard, Natural killer cell deficiency in patients with non-Hodgkin lymphoma after lung transplantation, The Journal of Heart and Lung Transplantation, 2015, 34, 4, 604

    CrossRef

  7. 7
    Bhawna Jha, Neelam Mohan, Smeeta Gajendra, Ritesh Sachdev, Shalini Goel, Tushar Sahni, Vimarsh Raina, A Soin, Prompt diagnosis and management of Epstein–Barr virus-associated post-transplant lymphoproliferative disorder and hemophagocytosis: A dreaded complication in a post-liver transplant child, Pediatric Transplantation, 2015, 19, 7
  8. 8
    Orla Maguire, Joseph D. Tario, Thomas C. Shanahan, Paul K. Wallace, Hans Minderman, Flow Cytometry and Solid Organ Transplantation: A Perfect Match, Immunological Investigations, 2014, 43, 8, 756

    CrossRef

  9. 9
    Mark Pedersen, Anil Seetharam, Infections After Orthotopic Liver Transplantation, Journal of Clinical and Experimental Hepatology, 2014, 4, 4, 347

    CrossRef

  10. 10
    I. Graziadei, Intensivmedizinisches Management vor und nach Lebertransplantation, Medizinische Klinik - Intensivmedizin und Notfallmedizin, 2014, 109, 6, 411

    CrossRef

  11. 11
    L. Ramirez-Avila, O. B. Garner, J. D. Cherry, Relative EBV antibody concentrations and cost of standard IVIG and CMV-IVIG for PTLD prophylaxis in solid organ transplant patients, Pediatric Transplantation, 2014, 18, 6
  12. 12
    Sidharth Mahapatra, Clifford C. Chin, Andrei Iagaru, Amy Heerema-McKenney, Clare J. Twist, Successful treatment of systemic and central nervous system post-transplant lymphoproliferative disorder without the use of high-dose methotrexate or radiation, Pediatric Blood & Cancer, 2014, 61, 11
  13. 13
    Josep M Grinyó, Klemens Budde, Franco Citterio, Bernard Charpentier, Belatacept utilization recommendations: an expert position, Expert Opinion on Drug Safety, 2013, 12, 1, 111

    CrossRef

  14. 14
    Sang-Oh Lee, Common Infections in Solid Organ Transplant Recipients, Korean Journal of Medicine, 2013, 84, 2, 145

    CrossRef

  15. 15
    Stephanie Ruf, Hans-Joachim Wagner, Determining EBV load: current best practice and future requirements, Expert Review of Clinical Immunology, 2013, 9, 2, 139

    CrossRef

  16. 16
    M. Green, M. G. Michaels, Epstein–Barr Virus Infection and Posttransplant Lymphoproliferative Disorder, American Journal of Transplantation, 2013, 13, s3
  17. 17
    Joseph G. Timpone, Raffaele Girlanda, Lauren Rudolph, Thomas M. Fishbein, Infections in Intestinal and Multivisceral Transplant Recipients, Infectious Disease Clinics of North America, 2013, 27, 2, 359

    CrossRef

  18. 18
    Daire T. O’Shea, Atul Humar, Life-Threatening Infection in Transplant Recipients, Critical Care Clinics, 2013, 29, 4, 953

    CrossRef

  19. You have free access to this content19
    Michael R. Lucey, Norah Terrault, Lolu Ojo, J. Eileen Hay, James Neuberger, Emily Blumberg, Lewis W. Teperman, Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation, Liver Transplantation, 2013, 19, 1
  20. 20
    Deirdre A. Kelly, John C. Bucuvalas, Estella M. Alonso, Saul J. Karpen, Upton Allen, Michael Green, Douglas Farmer, Eyal Shemesh, Ruth A. McDonald, Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation, Liver Transplantation, 2013, 19, 8
  21. 21
    Diana F Florescu, Alan N Langnas, Uriel Sandkovsky, Opportunistic viral infections in intestinal transplantation, Expert Review of Anti-infective Therapy, 2013, 11, 4, 367

    CrossRef

  22. 22
    Eric A. Engels, Barbara Savoldo, Ruth M. Pfeiffer, Rene Costello, Adriana Zingone, Helen E. Heslop, Ola Landgren, Plasma Markers of B-Cell Activation and Clonality in Pediatric Liver and Hematopoietic Stem Cell Transplant Recipients, Transplantation Journal, 2013, 95, 3, 519

    CrossRef

  23. 23
    Danielle K. Longmore, Louise S. Conwell, John R. Burke, Stephen P. McDonald, Steven J. McTaggart, Post-transplant lymphoproliferative disorder: No relationship to recombinant human growth hormone use in Australian and New Zealand pediatric kidney transplant recipients, Pediatric Transplantation, 2013, 17, 8
  24. 24
    Isabel P. Neuringer, Posttransplant Lymphoproliferative Disease after Lung Transplantation, Clinical and Developmental Immunology, 2013, 2013, 1

    CrossRef

  25. 25
    J. Bamoulid, C. Courivaud, A. Coaquette, J.-M. Chalopin, E. Gaiffe, P. Saas, D. Ducloux, Subclinical Epstein–Barr Virus Viremia Among Adult Renal Transplant Recipients: Incidence and Consequences, American Journal of Transplantation, 2013, 13, 3
  26. 26
    H. G. Haggerty, S. J. Proctor, Chronic Administration of Belatacept, a T-cell Costimulatory Signal Blocker, in Cynomolgus Monkeys, Toxicological Sciences, 2012, 127, 1, 159

    CrossRef

  27. 27
    E. A. Engels, J. Preiksaitis, A. Zingone, O. Landgren, Circulating Antibody Free Light Chains and Risk of Posttransplant Lymphoproliferative Disorder, American Journal of Transplantation, 2012, 12, 5
  28. 28
    M. S. Sampaio, Y. W. Cho, T. Shah, S. Bunnapradist, I. V. Hutchinson, Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients, Nephrology Dialysis Transplantation, 2012, 27, 7, 2971

    CrossRef

  29. 29
    Joan Gavaldà, Elisa Vidal, Carlos Lumbreras, Infection prevention in solid organ transplantation, Enfermedades Infecciosas y Microbiología Clínica, 2012, 30, 27

    CrossRef

  30. 30
    Jordi Carratalà, Miguel Montejo, Pilar Pérez-Romero, Infections caused by herpes viruses other than cytomegalovirus in solid organ transplant recipients, Enfermedades Infecciosas y Microbiología Clínica, 2012, 30, 63

    CrossRef

  31. 31
    M. Green, M. G. Michaels, Infections in Pediatric Solid Organ Transplant Recipients, Journal of the Pediatric Infectious Diseases Society, 2012, 1, 2, 144

    CrossRef

  32. 32
    A. Schwarz, Infektion nach Nierentransplantation, Der Nephrologe, 2012, 7, 4, 307

    CrossRef

  33. 33
    Katherine Twombley, Hanumantha Pokala, Monica I. Ardura, Paul Harker-Murray, Sarah F. Johnson-Welch, Arthur Weinberg, Mouin Seikaly, Intraventricular rituximab and systemic chemotherapy for treatment of central nervous system post-transplant lymphoproliferative disorder after kidney transplantation, Pediatric Transplantation, 2012, 16, 6
  34. 34
    Vidhya Murukesan, Sandeep Mukherjee, Managing Post-Transplant Lymphoproliferative Disorders in Solid-Organ Transplant Recipients, Drugs, 2012, 72, 12, 1631

    CrossRef

  35. 35
    Carol J. Holman, Amy B. Karger, Beth D. Mullan, Richard C. Brundage, Henry H. Balfour, Quantitative Epstein–Barr virus shedding and its correlation with the risk of post-transplant lymphoproliferative disorder, Clinical Transplantation, 2012, 26, 5
  36. 36
    Denis Glotz, Jeremy R. Chapman, Vikas R. Dharnidharka, Douglas W. Hanto, Maria C.R. Castro, Hans H. Hirsch, Véronique Leblond, Aneesh K. Mehta, Bruno Moulin, Antonio Pagliuca, Julio Pascual, Alan B. Rickinson, Francesco P. Russo, Ralf U. Trappe, Angela C. Webster, Andreas O. Zuckermann, Thomas G. Gross, The Seville Expert Workshop for Progress in Posttransplant Lymphoproliferative Disorders, Transplantation Journal, 2012, 94, 8, 784

    CrossRef

  37. 37
    Raymund R. Razonable, James Y. Findlay, Aisling O'Riordan, S. Gordon Burroughs, R. Mark Ghobrial, Banwari Agarwal, Andrew Davenport, Michael Gropper, Critical care issues in patients after liver transplantation, Liver Transplantation, 2011, 17, 5
  38. 38
    Soren Gantt, Corey Casper, Human herpesvirus 8-associated neoplasms, Current Opinion in Infectious Diseases, 2011, 24, 4, 295

    CrossRef

  39. 39
    SA Grim, NM Clark, Management of Infectious Complications in Solid-Organ Transplant Recipients, Clinical Pharmacology & Therapeutics, 2011, 90, 2
  40. 40
    Raymund R Razonable, Management of viral infections in solid organ transplant recipients, Expert Review of Anti-infective Therapy, 2011, 9, 6, 685

    CrossRef

  41. 41
    S. I. Martin, B. Dodson, C. Wheeler, J. Davis, T. Pesavento, G. L. Bumgardner, Monitoring Infection with Epstein–Barr Virus among Seromismatch Adult Renal Transplant Recipients, American Journal of Transplantation, 2011, 11, 5
  42. 42
    R. Baker, A. Jardine, Peter Andrews, Renal Association Clinical Practice Guideline on Post-operative Care of the Kidney Transplant Recipient, Nephron Clinical Practice, 2011, 118, s1, c311

    CrossRef

  43. 43
    Andrew J. Nowalk, Michael Green, Epstein-Barr virus–associated posttransplant lymphoproliferative disorder: Strategies for prevention and cure, Liver Transplantation, 2010, 16, S2
  44. 44
    M. Barton, S. Wasfy, D. Hébert, A. Dipchand, A. Fecteau, D. Grant, V. Ng, M. Solomon, M. Chan, S. Read, D. Stephens, R. Tellier, U. D. Allen, Exploring beyond viral load testing for EBV lymphoproliferation: Role of serum IL-6 and IgE assays as adjunctive tests, Pediatric Transplantation, 2010, 14, 7
  45. 45
    M. Green, M.G. Michaels, Loads, lungs, and lymphoproliferative disorders: role of Epstein–Barr virus and limitations of what we know, Transplant Infectious Disease, 2010, 12, 4
  46. 46
    Gerhard Opelz, Bernd Döhler, Pediatric Kidney Transplantation: Analysis of Donor Age, HLA Match, and Posttransplant Non-Hodgkin Lymphoma: A Collaborative Transplant Study Report, Transplantation, 2010, 90, 3, 292

    CrossRef

  47. 47
    Andrew J Nowalk, Michael Green, Update on EBV monitoring, detection and therapy in PTLD after solid organ transplant, Future Virology, 2010, 5, 3, 287

    CrossRef

  48. 48
    Rachel Hilton, Martin W. Drage, Infection,
  49. 49
    Jay A. Fishman, Robin K. Avery, Late Infectious Disease after Organ Transplantation,
  50. 50
    Toshihiro Okamoto, David Wheeler, Kenneth R. McCurry, Long-term Outcomes after Lung and Heart-Lung Transplantation,
  51. 51
    Daniel Kaul, Michael Green, Perioperative Infections after Organ Transplantation,
  52. 52
    Michael Green, Steven A. Webber, Post-Transplant Lymphoproliferative Disorders,